Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$535.7B | 5.7 | $0.0 99.5% overvalued | (59.1%) | $216.7M | ($55.8M) | (2.9%) | (25.8%) | 57.1% | (27.0%) | 6.0% | |
$489.8B | 5.3 | $0.0 99.9% overvalued | (4.8%) | $187.6M | $3,855.0K | 25.0% | 2.1% | 45.8% | (283.7%) | 0.0% | |
$211.4B | 5.6 | $0.0 99.8% overvalued | (83.5%) | £16.2M | (£43.9M) | (42.1%) | (270.5%) | 44.8% | (1,274.8%) | 0.1% | |
$166.0B | 4.6 | $3.4 93.4% overvalued | (18.4%) | $11.8B | ($369.0M) | (15.9%) | (3.1%) | 37.6% | 4.9% | 76.0% | |
$139.2B | 5.4 | $68.8 15.1% undervalued | (2.8%) | $203.3B | $18.2B | (10.9%) | 9.0% | 16.3% | 9.6% | 50.2% | |
$125.5B | 5.7 | $195.0 59.6% overvalued | 14.0% | $11.0B | ($790.3M) | 11.5% | (7.2%) | 86.1% | (15.0%) | 10.7% | |
$125.4B | 5.6 | $175.9 3.4% undervalued | (15.2%) | $66.5B | ($14.3B) | (14.5%) | (21.5%) | (3.0%) | (10.1%) | (1,376.2%) | |
$120.8B | 5.8 | $111.4 86.1% undervalued | 23.4% | $48.3B | $13.9B | 7.3% | 28.9% | 66.7% | 11.6% | 312.4% | |
$107.2B | 5.2 | $0.1 98.9% overvalued | (85.8%) | $112.1M | ($212.5M) | (9.1%) | (189.5%) | (32.0%) | (43.4%) | 0.4% | |
$100.5B | 5.5 | $76.9 26.0% undervalued | 0.9% | $80.6B | $11.5B | (33.1%) | 14.3% | 29.1% | 22.8% | 23.9% | |
$96.2B | 7.1 | $89.0 55.3% undervalued | 56.6% | $20.4B | $5,318.0M | (4.9%) | 26.0% | 70.3% | 70.1% | (2,208.6%) | |
$78.2B | 6.4 | $54.0 37.1% overvalued | 8.5% | $5,376.4M | $1,411.3M | (2.2%) | 26.2% | 39.6% | (7.3%) | 30.6% | |
$73.5B | 6.4 | $207.3 24.4% overvalued | 32.1% | $4,795.0M | $1,392.6M | 23.2% | 29.0% | 81.7% | (16.5%) | 102.0% | |
$61.5B | 6.4 | $177.6 62.7% undervalued | (25.9%) | £33.2B | £3,907.8M | 17.9% | 11.8% | 59.8% | 36.9% | 154.2% | |
$59.5B | 6.2 | $111.7 35.6% overvalued | (2.4%) | $3,626.4M | $900.1M | 29.2% | 24.8% | 66.5% | (58.3%) | 87.1% | |
$58.3B | 6.2 | $19.9 92.1% overvalued | 88.1% | $463.5M | ($22.1B) | (6.6%) | (4,777.0%) | 72.1% | (19.7%) | 0.6% | |
$55.4B | 5.9 | $60.3 27.2% undervalued | 16.6% | $187.4B | ($5,980.0M) | 9.1% | (3.2%) | 12.5% | 9.2% | 1.5% | |
$50.7B | 5.9 | $46.3 67.6% overvalued | 41.7% | $1,669.6M | $166.9M | 28.8% | 10.0% | 77.3% | (16.5%) | 139.9% | |
$42.8B | 6.4 | $15.4 75.2% overvalued | 56.8% | $2,613.8M | $758.5M | (6.6%) | 29.0% | 36.5% | (55.0%) | 321.1% | |
$40.7B | 6.1 | $114.3 9.0% overvalued | (17.1%) | $36.7B | $2,872.2M | 2.1% | 7.8% | 25.7% | 13.1% | 20.2% |
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Stay informed on the latest stocks trading at 52-week lows, highlighting those facing downward pressure in the market.
Explore 20 stocks in the Warren Buffett favorites stocks portfolio 2025, managed by Berkshire Hathaway.